Art Krieg
@artkrieg.bsky.social
Love trail running, hiking, Toll-Like receptors 7/8/9, P1 pDC. Founder/CEO of Zola Therapeutics
Reposted by Art Krieg
As a someone with a 33 year NIH-funded lab whose grant is supposed to be reviewed this week, shut NIH down if that is what's needed to end ICE terrorism. Innocent lives are more important 🧪
The Senate may choose to vote together on the DHS and LHHS bills. Thus, a filibuster on DHS may mean no funding for NIH. What my colleagues are saying:
“Shut it down, public health will understand. I’ll work without pay again.”
- anonymous NIHer
“Shut it down, public health will understand. I’ll work without pay again.”
- anonymous NIHer
January 25, 2026 at 12:59 PM
As a someone with a 33 year NIH-funded lab whose grant is supposed to be reviewed this week, shut NIH down if that is what's needed to end ICE terrorism. Innocent lives are more important 🧪
Reposted by Art Krieg
Point blank.
10-shots.
Execution.
A US citizen, a VA ICU Nurse.
Then lying.
Blocking a real investigation.
10-shots.
Execution.
A US citizen, a VA ICU Nurse.
Then lying.
Blocking a real investigation.
January 26, 2026 at 1:00 AM
Point blank.
10-shots.
Execution.
A US citizen, a VA ICU Nurse.
Then lying.
Blocking a real investigation.
10-shots.
Execution.
A US citizen, a VA ICU Nurse.
Then lying.
Blocking a real investigation.
Reposted by Art Krieg
Reposted by Art Krieg
Why can't corporate media use this straight-up language? It's not complicated.
Federal Agents Kill Again; Gunmen Still At Large | Defector
On Saturday in Minneapolis, federal agents surrounded 37-year-old Veterans Affairs intensive care nurse Alex Jeffrey Pretti, who’d been filming them in the street with his phone camera as they conduct...
defector.com
January 25, 2026 at 1:54 PM
Why can't corporate media use this straight-up language? It's not complicated.
Reposted by Art Krieg
The story is not that there are two conflicting versions of what happened.
The story is that the federal government is lying about what happened.
There is plenty of evidence.
Your job, our job, is to sift that evidence and describe what actually happened ffs.
The story is that the federal government is lying about what happened.
There is plenty of evidence.
Your job, our job, is to sift that evidence and describe what actually happened ffs.
January 25, 2026 at 11:33 AM
The story is not that there are two conflicting versions of what happened.
The story is that the federal government is lying about what happened.
There is plenty of evidence.
Your job, our job, is to sift that evidence and describe what actually happened ffs.
The story is that the federal government is lying about what happened.
There is plenty of evidence.
Your job, our job, is to sift that evidence and describe what actually happened ffs.
May we all be Alex. Our government murdered him, lied about it, and are trying to obstruct justice. We the people demand justice.
A video of Alex Pretti reading out the final salute of an unnamed veteran he cared for until the end of his life in the ICU, posted to Facebook by his son.
January 25, 2026 at 1:02 PM
May we all be Alex. Our government murdered him, lied about it, and are trying to obstruct justice. We the people demand justice.
Just got my poster set up at #SITC2025 and walking my first visitor through our data. If you’re here, stop by poster 919 to learn about the unique biology of TLR7/8/9!
November 7, 2025 at 2:53 PM
Just got my poster set up at #SITC2025 and walking my first visitor through our data. If you’re here, stop by poster 919 to learn about the unique biology of TLR7/8/9!
Delighted that Luke Timmerman invited me on his Long Run podcast to tell Zola's story. It's been a long run for me, from discovering CpG DNA (TLR9) 30 yrs ago, to now discovering RNA/DNA TLR7/8/9 agonists, which may transform cancer immunotherapy!
timmermanreport.com/2025/10/inna...
timmermanreport.com/2025/10/inna...
Innate Immune System Activators for Cancer: Art Krieg on The Long Run - TimmermanReport.com
Art Krieg is today’s guest on The Long Run. Art is the founder and CEO of a Cambridge, Mass.-based startup called Zola Therapeutics. Zola is developing an oligonucleotide drug candidate to activate a ...
timmermanreport.com
October 28, 2025 at 10:20 PM
Delighted that Luke Timmerman invited me on his Long Run podcast to tell Zola's story. It's been a long run for me, from discovering CpG DNA (TLR9) 30 yrs ago, to now discovering RNA/DNA TLR7/8/9 agonists, which may transform cancer immunotherapy!
timmermanreport.com/2025/10/inna...
timmermanreport.com/2025/10/inna...
Reposted by Art Krieg
Join us for the 3rd Nature Conference on Nucleic Acid Medicines in Boston (Dec 8-10) with an amazing lineup of speakers. 4 weeks left 4 early bird registration! natureconferences.streamgo.live/cracking-the...
@natureportfolio.nature.com @nature.com @natbiotech.nature.com @natrevdrugdiscov.nature.com
@natureportfolio.nature.com @nature.com @natbiotech.nature.com @natrevdrugdiscov.nature.com
September 17, 2025 at 6:02 AM
Join us for the 3rd Nature Conference on Nucleic Acid Medicines in Boston (Dec 8-10) with an amazing lineup of speakers. 4 weeks left 4 early bird registration! natureconferences.streamgo.live/cracking-the...
@natureportfolio.nature.com @nature.com @natbiotech.nature.com @natrevdrugdiscov.nature.com
@natureportfolio.nature.com @nature.com @natbiotech.nature.com @natrevdrugdiscov.nature.com
My new review article covers key points I have not seen in any other review of cancer immunotherapy: i) the difference between IFN-a and IFN-b; ii) the unique role of P1 pDC among all DC subsets; iii) the unique role of TLR7/8/9 among TLRs
nam10.safelinks.protection.outlook.com?url=http%3A%...
nam10.safelinks.protection.outlook.com?url=http%3A%...
New insights into the role of IFN-α/β and TLR7/8/9 in cancer immunotherapy and systemic autoimmunity
The role of type I interferon (IFN) in mediating tumor immunosurveillance, in situ vaccination, and response to other cancer immunotherapies is well established. The biologic and species-specific diff...
nam10.safelinks.protection.outlook.com
September 19, 2025 at 12:57 PM
My new review article covers key points I have not seen in any other review of cancer immunotherapy: i) the difference between IFN-a and IFN-b; ii) the unique role of P1 pDC among all DC subsets; iii) the unique role of TLR7/8/9 among TLRs
nam10.safelinks.protection.outlook.com?url=http%3A%...
nam10.safelinks.protection.outlook.com?url=http%3A%...
If you are an academic innovator interested in learning more about translating your research to real-world impact, apply to be a Termeer Scholar! Get your application in by Friday, August 29th at Midnight EST to be considered for this incredible opportunity!
www.linkedin.com/posts/termee...
www.linkedin.com/posts/termee...
#termeerscholars #academicinnovation #lifesciences #biotech #healthcareimpact #techtransfer #commercialization #patientdrivenscience #benchtobedside #labtopatientjourney | Termeer Institute
Only 3 days remain to apply for the Termeer Scholars Program!
Why Apply?
Join a two-day workshop designed to support your journey from the bench to bedside. You'll gain practical skills, industry ins...
www.linkedin.com
August 27, 2025 at 2:16 PM
If you are an academic innovator interested in learning more about translating your research to real-world impact, apply to be a Termeer Scholar! Get your application in by Friday, August 29th at Midnight EST to be considered for this incredible opportunity!
www.linkedin.com/posts/termee...
www.linkedin.com/posts/termee...
I recently had the pleasure of joining
The Pharmaverse podcast - it released today. We discussed the parallels between running marathons (and ultras) and my >30 yrs of efforts activating immunity to fight cancer, culminating in founding Zola Rx, starting a biotech is harder! youtu.be/FX9MLqv9PBQ
The Pharmaverse podcast - it released today. We discussed the parallels between running marathons (and ultras) and my >30 yrs of efforts activating immunity to fight cancer, culminating in founding Zola Rx, starting a biotech is harder! youtu.be/FX9MLqv9PBQ
Season 2, Episode 13: Finding A Path Forward with Art Krieg
YouTube video by The Pharmaverse Podcast
youtu.be
July 7, 2025 at 7:42 PM
I recently had the pleasure of joining
The Pharmaverse podcast - it released today. We discussed the parallels between running marathons (and ultras) and my >30 yrs of efforts activating immunity to fight cancer, culminating in founding Zola Rx, starting a biotech is harder! youtu.be/FX9MLqv9PBQ
The Pharmaverse podcast - it released today. We discussed the parallels between running marathons (and ultras) and my >30 yrs of efforts activating immunity to fight cancer, culminating in founding Zola Rx, starting a biotech is harder! youtu.be/FX9MLqv9PBQ
Like most immunologists, I tend to use a lot of jargon when talking about cancer immunotherapy - so complex! A patient in one of our prior clinical trials asked me to explain our new approach with TLR7/8/9 agonists, and I made this video on the history, which he liked. youtu.be/KLgCU5Gm3pA
A brief history of cancer immunotherapy, for non-immunologists and patients
YouTube video by Art Krieg
youtu.be
June 4, 2025 at 5:31 PM
Like most immunologists, I tend to use a lot of jargon when talking about cancer immunotherapy - so complex! A patient in one of our prior clinical trials asked me to explain our new approach with TLR7/8/9 agonists, and I made this video on the history, which he liked. youtu.be/KLgCU5Gm3pA
Thank you Brad Loncar for hosting us on Biotech TV - Jim and I appreciated the chance to explain how a deeper understanding of type one IFNs can propel cancer immunotherapy forward to greater success! RNA/DNA hybrids costimulate TLR7/8/9, inducing a novel IFN-a response without inflammation!
𝐓𝐡𝐞 𝐒𝐭𝐮𝐝𝐢𝐨 𝐚𝐭 𝐊𝐞𝐧𝐝𝐚𝐥𝐥 𝐒𝐪𝐮𝐚𝐫𝐞: Biotech veteran @artkrieg.bsky.social explains the science behind his newest immunotherapy company, Zola Therapeutics, which uses both RNA and DNA agonists delivered in an LNP.
Full video: www.biotechtv.com/post/zola-th...
Full video: www.biotechtv.com/post/zola-th...
April 23, 2025 at 12:48 PM
Thank you Brad Loncar for hosting us on Biotech TV - Jim and I appreciated the chance to explain how a deeper understanding of type one IFNs can propel cancer immunotherapy forward to greater success! RNA/DNA hybrids costimulate TLR7/8/9, inducing a novel IFN-a response without inflammation!
Can Cambridge biotech evolve with the times? I’m an optimist, but the challenges we face are clear and growing…
February 14, 2025 at 2:33 PM
Can Cambridge biotech evolve with the times? I’m an optimist, but the challenges we face are clear and growing…
Reposted by Art Krieg
Tickets are SOLD OUT for the TR10 East Coast anniversary party Mar. 6 in Cambridge, Mass. Tickets still available for TR10 West Coast party Mar. 13. Register here. www.eventbrite.com/e/tr10-west-...
TR10 West Coast Party
TR10 West Coast Party. Join a stellar cast of biotech leaders at the TR10 West Coast Party for toasts and roasts of founder Luke Timmerman.
www.eventbrite.com
February 11, 2025 at 12:16 AM
Tickets are SOLD OUT for the TR10 East Coast anniversary party Mar. 6 in Cambridge, Mass. Tickets still available for TR10 West Coast party Mar. 13. Register here. www.eventbrite.com/e/tr10-west-...
Cold day going up Mount Washington today with Doug Fambrough, Dave Melville, Jim Ellis, and friends! On the way up, Doug agreed to join me on the board of my new company, Zola therapeutics, getting work done while having fun!
January 26, 2025 at 12:50 AM
Cold day going up Mount Washington today with Doug Fambrough, Dave Melville, Jim Ellis, and friends! On the way up, Doug agreed to join me on the board of my new company, Zola therapeutics, getting work done while having fun!
A drug comprising 8 defined live bacterial strains reduces C diff. by >80%, cool!
Today our team published additional results from the Phase 2 CONSORTIUM study for our lead candidate, VE303, a potential first-in-class Live Biotherapeutic Product which is being evaluated for prevention of recurrent Clostridioides difficile infection (rCDI).
full-text access: rdcu.be/d5ovX
full-text access: rdcu.be/d5ovX
Multi-omic profiling a defined bacterial consortium for treatment of recurrent Clostridioides difficile infection
Nature Medicine - Results of multi-omic profiling of the microbiome and host immunity of individuals treated with VE303 to prevent recurrent Clostridioides difficile infection in the context of a...
rdcu.be
January 3, 2025 at 2:16 AM
A drug comprising 8 defined live bacterial strains reduces C diff. by >80%, cool!
Reposted by Art Krieg
I joined 75+ @nobelprize.bsky.social laureates urging US Senators to oppose RFK Jr.'s confirmation as DHHS Secretary. If you’re in a state with GOP senators, PLEASE reach out to them! I’d deeply appreciate it if you amplified this post! 🙏
www.nytimes.com/2024/12/09/h...
www.nytimes.com/2024/12/09/h...
December 9, 2024 at 11:19 PM
I joined 75+ @nobelprize.bsky.social laureates urging US Senators to oppose RFK Jr.'s confirmation as DHHS Secretary. If you’re in a state with GOP senators, PLEASE reach out to them! I’d deeply appreciate it if you amplified this post! 🙏
www.nytimes.com/2024/12/09/h...
www.nytimes.com/2024/12/09/h...
Mount Lafayette and Franconia Ridge are completely different in the winter, my favorite time of year to be up here!#AnotherGreatDayInTheMountains
December 1, 2024 at 3:37 PM
Mount Lafayette and Franconia Ridge are completely different in the winter, my favorite time of year to be up here!#AnotherGreatDayInTheMountains
It’s another great day to be in the mountains! Heading up the Old Bridle Path in Franconia notch…
December 1, 2024 at 2:07 PM
It’s another great day to be in the mountains! Heading up the Old Bridle Path in Franconia notch…
It’s full on winter on Mount Washington, but the Lake of the Clouds hut still provides a nice wind break for hot coffee and a snack. Excellent conditions snowshoeing up ammo. Just past the hut, the trail disappears under deep drifts and there’s no visibility with blowing snow. Back down ammo!
November 30, 2024 at 7:23 PM
It’s full on winter on Mount Washington, but the Lake of the Clouds hut still provides a nice wind break for hot coffee and a snack. Excellent conditions snowshoeing up ammo. Just past the hut, the trail disappears under deep drifts and there’s no visibility with blowing snow. Back down ammo!
Sunset right now in the blue Hills, the rocks are still a bit wet from the recent rain, so I’m taking it easy, enjoying the views!
November 23, 2024 at 9:10 PM
Sunset right now in the blue Hills, the rocks are still a bit wet from the recent rain, so I’m taking it easy, enjoying the views!
For my inaugural post, I’m sharing this recent talk on the immune considerations in mRNA therapeutics. Optimizing CD8+ T cell responses requires understanding the biology of IFN-a/b, which has been ignored in recent cancer immunotherapy review articles.
youtu.be/Isz5FqRpqbM
youtu.be/Isz5FqRpqbM
mRNA Therapeutics: immunological issues (from 9th Int. Vaccines R&D Conference, Boston, Nov. 2024)
YouTube video by Art Krieg
youtu.be
November 23, 2024 at 4:00 PM
For my inaugural post, I’m sharing this recent talk on the immune considerations in mRNA therapeutics. Optimizing CD8+ T cell responses requires understanding the biology of IFN-a/b, which has been ignored in recent cancer immunotherapy review articles.
youtu.be/Isz5FqRpqbM
youtu.be/Isz5FqRpqbM